Raymond James Financial Inc. Invests $6.61 Million in Oscar Health, Inc. (NYSE:OSCR)

Raymond James Financial Inc. bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 492,046 shares of the company's stock, valued at approximately $6,613,000. Raymond James Financial Inc. owned about 0.20% of Oscar Health at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. Victory Capital Management Inc. grew its holdings in shares of Oscar Health by 42.4% during the 3rd quarter. Victory Capital Management Inc. now owns 58,353 shares of the company's stock worth $1,238,000 after purchasing an additional 17,377 shares during the period. Swiss National Bank lifted its position in Oscar Health by 17.8% during the third quarter. Swiss National Bank now owns 314,900 shares of the company's stock valued at $6,679,000 after buying an additional 47,500 shares in the last quarter. Intech Investment Management LLC purchased a new stake in Oscar Health during the third quarter worth approximately $1,282,000. Charles Schwab Investment Management Inc. increased its position in shares of Oscar Health by 20.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company's stock worth $33,940,000 after acquiring an additional 270,223 shares in the last quarter. Finally, Kingsview Wealth Management LLC purchased a new position in shares of Oscar Health in the 3rd quarter valued at $446,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently weighed in on OSCR. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Jefferies Financial Group started coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $20.21.

Remove Ads

Oscar Health Stock Down 2.3 %

OSCR traded down $0.31 on Thursday, reaching $13.45. The company's stock had a trading volume of 2,294,407 shares, compared to its average volume of 4,655,820. Oscar Health, Inc. has a 1 year low of $12.43 and a 1 year high of $23.79. The business's 50 day moving average is $14.99 and its 200 day moving average is $16.14. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $3.37 billion, a price-to-earnings ratio of -672.01 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.